Study 3 of 4Afamelanotide literatureThe New England journal of medicineTop journal2015
Afamelanotide for Erythropoietic Protoporphyria.
Not reported in abstract.
Where it sits
this study against the rest of the afamelanotide corpus2
Preclinical · this one
2
Observational
0
Open-label
0
Randomised
0
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2015
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Afamelanotide corpus
DProtection: the sunscreen pill.Nature · 2014—BPatient journey and disparities in the diagnosis and treatment of patients with hidradenitis suppurativa.JID innovations : skin science from molecules to population health · 2026 · n=3065 · Adult patients with HS had lower overall costs ($22,128 ± $61,671) compared to those with suspected HS ($36,359 ± $82,762).HumanBRisk factors for poor prognosis in patients with cortical laminar necrosis and establishment of their prediction model: A retrospective cohort study.Medicine · 2024 · n=80 · Admission NIHSS score (OR = 1.317; 95% CI 1.097-1.669; P = .008)Human